Terms: = Bone cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
315 results:
1. [Drastic changes in the treatment of metastatic prostate cancer].
Thellenberg Karlsson C; Ståhl O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38651316
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
[TBL] [Abstract] [Full Text] [Related]
3. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.
Ringdén O; Sadeghi B
Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331
[TBL] [Abstract] [Full Text] [Related]
4. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
5. [BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian cancer-Two Germline Pathogenic Variants Aligned in the Cis Position].
Yukisawa S; Kakinuma T; Yotsumoto J; Kawakami K; Furukawa J; Shinozaki H
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1089-1091. PubMed ID: 38035841
[TBL] [Abstract] [Full Text] [Related]
6. SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal bone Biopsy Procedure: BOP).
Cimadamore A; Rescigno P; Conteduca V; Caliò A; Allegritti M; Calò V; Montagnani I; Lucianò R; Patruno M; Bracarda S;
Virchows Arch; 2023 Nov; 483(5):579-589. PubMed ID: 37794204
[TBL] [Abstract] [Full Text] [Related]
7. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
[TBL] [Abstract] [Full Text] [Related]
8. The Elusive Primary: Metastatic Adenocarcinoma of the Breast Presenting Solely as a Hard Sternal Mass.
Mohd Omar R; Ismail IA; Md Yasin M; Ahmad Affandi K; Hasbullah HH; Mohamad Ali ND
Am J Case Rep; 2023 Aug; 24():e940594. PubMed ID: 37608536
[TBL] [Abstract] [Full Text] [Related]
9. Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.
Moreno M; Oliveira JS; Brianese RC; de Castro DG; Sanches SM; Torrezan GT; Santiago KM; De Brot M; Cordeiro de Lima VC; Baroni Alves Makdissi F; Casali Da Rocha JC; Calsavara VF; Carraro DM
Cancer Med; 2023 Aug; 12(15):16129-16141. PubMed ID: 37485802
[TBL] [Abstract] [Full Text] [Related]
10. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract] [Full Text] [Related]
11. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
[TBL] [Abstract] [Full Text] [Related]
12. Changes in bone Density in Carriers of brca1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy.
Chan LN; Chen LM; Goldman M; Mak JS; Bauer DC; Boscardin J; Schembri M; Bae-Jump V; Friedman S; Jacoby VL
Obstet Gynecol; 2023 Jul; 142(1):160-169. PubMed ID: 37290104
[TBL] [Abstract] [Full Text] [Related]
13. Prevalence and characteristics of benign cartilaginous tumours of the knee joint as identified on MRI scans.
Woltsche JN; Smolle MA; Szolar D; Bergovec M; Leithner A
Cancer Imaging; 2023 May; 23(1):50. PubMed ID: 37231453
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of bone Marrow Biopsy Results From MRI in Multiple Myeloma Patients Using Deep Learning and Radiomics.
Wennmann M; Ming W; Bauer F; Chmelik J; Klein A; Uhlenbrock C; Grözinger M; Kahl KC; Nonnenmacher T; Debic M; Hielscher T; Thierjung H; Rotkopf LT; Stanczyk N; Sauer S; Jauch A; Götz M; Kurz FT; Schlamp K; Horger M; Afat S; Besemer B; Hoffmann M; Hoffend J; Kraemer D; Graeven U; Ringelstein A; Bonekamp D; Kleesiek J; Floca RO; Hillengass J; Mai EK; Weinhold N; Weber TF; Goldschmidt H; Schlemmer HP; Maier-Hein K; Delorme S; Neher P
Invest Radiol; 2023 Oct; 58(10):754-765. PubMed ID: 37222527
[TBL] [Abstract] [Full Text] [Related]
15. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
16. Negative pressure induces dedifferentiation of hepatocytes via RhoA/ROCK pathway.
Khalifa MO; Moriwaki T; Zhang S; Zhou W; Ito K; Li TS
Biochem Biophys Res Commun; 2023 Jul; 667():104-110. PubMed ID: 37210870
[TBL] [Abstract] [Full Text] [Related]
17. iris and orbital myeloid sarcoma in a pediatric patient.
Qin VL; Verkuil L; Zanganeh T; Wertheim G; Davidson SL
J AAPOS; 2023 Jun; 27(3):157-160. PubMed ID: 37207926
[TBL] [Abstract] [Full Text] [Related]
18. Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
Nebgen DR; Domchek SM; Kotsopoulos J; de Hullu JA; Crosbie EJ; Paramanandam VS; Brood-van Zanten MMA; Norquist BM; Guise T; Rozenberg S; Kurian AW; Pederson HJ; Yuksel N; Michaelson-Cohen R; Bober SL; da Silva Filho AL; Johansen N; Guidozzi F; Evans DG; Menon U; Kingsberg SA; Powell CB; Grandi G; Marchetti C; Jacobson M; Brennan DJ; Hickey M
BJOG; 2023 Nov; 130(12):1437-1450. PubMed ID: 37132126
[TBL] [Abstract] [Full Text] [Related]
19. Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medication.
Okunola AO; Baatjes KJ; Zemlin AE; Torrorey-Sawe R; Conradie M; Kidd M; Erasmus RT; van der Merwe NC; Kotze MJ
Expert Rev Mol Diagn; 2023 May; 23(5):431-443. PubMed ID: 37060281
[TBL] [Abstract] [Full Text] [Related]
20. Differences between zoledronic acid and denosumab for breast cancer treatment.
Ishikawa T
J Bone Miner Metab; 2023 May; 41(3):301-306. PubMed ID: 36879056
[TBL] [Abstract] [Full Text] [Related]
[Next]
